DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 201923
» See Plans and Pricing
The generic ingredient in ILUVIEN is fluocinolone acetonide. There are twelve drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the fluocinolone acetonide profile page.
Summary for 201923
Tradename: | ILUVIEN |
Applicant: | Alimera Sciences Inc |
Ingredient: | fluocinolone acetonide |
Patents: | 2 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 201923
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Medical Subject Heading (MeSH) Categories for 201923
Suppliers and Packaging for NDA: 201923
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ILUVIEN | fluocinolone acetonide | IMPLANT;INTRAVITREAL | 201923 | NDA | Alimera Sciences, Inc. | 68611-190 | 68611-190-02 | 1 TRAY in 1 CARTON (68611-190-02) > 1 APPLICATOR in 1 TRAY > 1 IMPLANT in 1 APPLICATOR |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | IMPLANT;INTRAVITREAL | Strength | 0.19MG | ||||
Approval Date: | Sep 26, 2014 | TE: | RLD: | Yes | |||||
Patent: | Start Trial | Patent Expiration: | Apr 26, 2020 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Patented Use: | TREATMENT OF DIABETIC MACULAR EDEMA | ||||||||
Patent: | Start Trial | Patent Expiration: | Aug 12, 2027 | Product Flag? | Y | Substance Flag? | Delist Request? |
Expired US Patents for NDA 201923
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Alimera Sciences Inc | ILUVIEN | fluocinolone acetonide | IMPLANT;INTRAVITREAL | 201923-001 | Sep 26, 2014 | Start Trial | Start Trial |
Alimera Sciences Inc | ILUVIEN | fluocinolone acetonide | IMPLANT;INTRAVITREAL | 201923-001 | Sep 26, 2014 | Start Trial | Start Trial |
Alimera Sciences Inc | ILUVIEN | fluocinolone acetonide | IMPLANT;INTRAVITREAL | 201923-001 | Sep 26, 2014 | Start Trial | Start Trial |
Alimera Sciences Inc | ILUVIEN | fluocinolone acetonide | IMPLANT;INTRAVITREAL | 201923-001 | Sep 26, 2014 | Start Trial | Start Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription